agilon health, inc. (NYSE:AGL) Position Reduced by Deutsche Bank AG

Deutsche Bank AG trimmed its position in shares of agilon health, inc. (NYSE:AGL - Free Report) by 42.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,205,026 shares of the company's stock after selling 882,390 shares during the quarter. Deutsche Bank AG owned approximately 0.29% of agilon health worth $2,290,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of AGL. Vanguard Group Inc. raised its position in shares of agilon health by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company's stock worth $59,114,000 after purchasing an additional 272,787 shares during the last quarter. Capital International Investors increased its position in agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after buying an additional 9,346,295 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of agilon health by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company's stock worth $13,168,000 after acquiring an additional 35,207 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of agilon health by 49.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock valued at $8,629,000 after acquiring an additional 1,498,524 shares in the last quarter. Finally, Northern Trust Corp lifted its position in shares of agilon health by 13.0% in the fourth quarter. Northern Trust Corp now owns 2,962,350 shares of the company's stock valued at $5,628,000 after acquiring an additional 340,304 shares in the last quarter.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Royal Bank of Canada lifted their price objective on agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. Cowen reissued a "hold" rating on shares of agilon health in a research note on Tuesday, April 15th. Sanford C. Bernstein raised shares of agilon health from a "market perform" rating to an "outperform" rating and lifted their target price for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. The Goldman Sachs Group upped their target price on agilon health from $2.50 to $5.00 and gave the company a "neutral" rating in a research note on Thursday, May 8th. Finally, Stifel Nicolaus raised their price target on agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a research note on Wednesday, February 26th. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $4.79.

agilon health Stock Performance

AGL traded up $0.06 during trading hours on Wednesday, hitting $2.29. 802,124 shares of the stock were exchanged, compared to its average volume of 5,777,007. The stock has a 50-day simple moving average of $3.92 and a 200-day simple moving average of $3.18. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $7.73. The stock has a market cap of $945.88 million, a price-to-earnings ratio of -2.43 and a beta of 0.38.

agilon health (NYSE:AGL - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.50 billion. During the same quarter in the previous year, the firm posted ($0.02) EPS. The business's revenue for the quarter was down 4.5% compared to the same quarter last year. Analysts anticipate that agilon health, inc. will post -0.59 earnings per share for the current year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.